These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 28475008

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Suppression of SIRT6 by miR-33a facilitates tumor growth of glioma through apoptosis and oxidative stress resistance.
    Chang M, Qiao L, Li B, Wang J, Zhang G, Shi W, Liu Z, Gu N, Di Z, Wang X, Tian Y.
    Oncol Rep; 2017 Aug; 38(2):1251-1258. PubMed ID: 28677777
    [Abstract] [Full Text] [Related]

  • 25. MiR-210 up-regulation inhibits proliferation and induces apoptosis in glioma cells by targeting SIN3A.
    Shang C, Hong Y, Guo Y, Liu YH, Xue YX.
    Med Sci Monit; 2014 Dec 07; 20():2571-7. PubMed ID: 25481483
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. CircNFIX promotes progression of glioma through regulating miR-378e/RPN2 axis.
    Ding C, Wu Z, You H, Ge H, Zheng S, Lin Y, Wu X, Lin Z, Kang D.
    J Exp Clin Cancer Res; 2019 Dec 30; 38(1):506. PubMed ID: 31888753
    [Abstract] [Full Text] [Related]

  • 30. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
    Liu Y, Zhang G, Li H, Han L, Fu A, Zhang N, Zheng Y.
    Biomed Pharmacother; 2015 Oct 30; 75():185-90. PubMed ID: 26337230
    [Abstract] [Full Text] [Related]

  • 31. MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC.
    Sasayama T, Nishihara M, Kondoh T, Hosoda K, Kohmura E.
    Int J Cancer; 2009 Sep 15; 125(6):1407-13. PubMed ID: 19536818
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Down-regulation of MicroRNA-133 predicts poor overall survival and regulates the growth and invasive abilities in glioma.
    Liu Y, Han L, Bai Y, Du W, Yang B.
    Artif Cells Nanomed Biotechnol; 2018 Feb 15; 46(1):206-210. PubMed ID: 28376685
    [Abstract] [Full Text] [Related]

  • 36. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X, Chen S, Xiu YL, Sun KX, Zong ZH, Zhao Y.
    Mol Cancer; 2015 Feb 04; 14(1):31. PubMed ID: 25649143
    [Abstract] [Full Text] [Related]

  • 37. Serum MicroRNA-125b as a Potential Biomarker for Glioma Diagnosis.
    Wei X, Chen D, Lv T, Li G, Qu S.
    Mol Neurobiol; 2016 Jan 04; 53(1):163-170. PubMed ID: 25416859
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.